CONDITION
Pyoderma in Dogs
Pyoderma is a bacterial infection of the skin. It occurs when bacteria, most often those that live harmlessly on the skin's surface under normal conditions, multiply within or beneath the outer layers and trigger inflammation. The depth and pattern of that infection shape what an owner observes. Many owners notice redness, small raised bumps, crusts, or circular patches of hair loss. Some dogs develop a distinctive smell or begin licking or scratching at affected areas. The appearance can range from a few scattered spots to widespread change across the body, and the signs can look very different depending on whether the infection involves only the surface or extends into deeper layers of skin. This page explores the signals that may point towards pyoderma, the factors that allow infection to take hold, how the condition is investigated, and the range of approaches used to address it—including topical treatments, systemic options, and the management of underlying contributors.
Why this matters now
Pyoderma can emerge at any age, though certain patterns appear more often in particular groups. Young dogs may develop their first episode during adolescence, when hormonal shifts and exploratory behaviour bring new exposures. Breeds with skin folds, dense coats, or inherited tendencies toward allergic skin disease tend to see pyoderma more frequently. Environmental factors such as humidity, warm weather, and contact with wet or muddy surfaces can favour bacterial overgrowth, while seasonal allergens may trigger the underlying inflammation that allows infection to take hold.
The timeline varies considerably between individuals and depends largely on what sits beneath the infection. A surface infection may appear quite suddenly, often within days of a triggering event such as a scratch or a period of intense licking. If an underlying cause remains unaddressed, the infection may resolve with initial management only to recur weeks or months later. In cases where deeper layers of skin are involved, the progression tends to be slower, with lesions expanding outward or deepening over the course of one to several weeks.
Signals & patterns
Early signals
Small red bumps or pustules
These often appear as scattered raised spots, sometimes with a tiny white or yellow centre. They may be found on the belly, groin, or areas where the coat is thinner, and can be easier to feel than to see in dogs with thick fur.
Increased licking or nibbling
A dog may begin to focus attention on a particular area, licking or gently chewing at the skin. This behaviour often reflects discomfort or itch, and the moisture from saliva can itself encourage further bacterial multiplication.
Circular patches with crusts
Some dogs develop round lesions with a scaly or crusted rim and a darker centre, sometimes called epidermal collarettes. These may spread outward slowly and can appear quite symmetrical.
Thinning hair or small bald spots
Hair may be lost in small patches, often where pustules have formed and ruptured. The skin beneath can look pink or slightly darker than usual, and may feel warm to the touch.
Mild unpleasant odour
A faintly sweet or musty smell can become noticeable, particularly in areas where moisture collects. This reflects bacterial activity and the breakdown of skin cells and inflammatory debris.
Later signals
Weeping or moist areas
The skin may begin to ooze a sticky, honey-coloured or greenish fluid. These moist spots often develop where the infection has spread or deepened, and the surrounding coat may become matted.
Thickened or darkened skin
Chronic or recurrent infection can lead to visible changes in texture and colour. The skin may feel leathery, appear grey or blackened, and lose its usual flexibility, particularly in areas that have been repeatedly inflamed.
Nodules or draining tracts
In deeper infections, firm lumps may form beneath the skin, and some may develop openings that discharge pus or blood. These lesions tend to be painful and can take longer to resolve.
Generalised discomfort or restlessness
A dog with more extensive or deeper pyoderma may show signs of feeling generally unwell, shifting position frequently, avoiding touch, or appearing less settled than usual.
Click to read about the biological mechanisms
How this is usually investigated
Investigation of pyoderma aims to confirm the bacterial infection, identify any underlying triggers, and guide appropriate antimicrobial selection, particularly in recurrent or treatment-resistant cases.
Skin cytology
Bacterial culture and sensitivity
Skin scraping and parasitic investigation
Allergy investigation
Endocrine testing
Options & trade-offs
Treatment of pyoderma addresses both the bacterial infection itself and any underlying triggers that predispose to recurrence. The approach varies with the depth and extent of infection and the presence of antibiotic-resistant organisms.
Topical antimicrobial therapy
Medicated shampoos, sprays, mousses, and wipes containing chlorhexidine, benzoyl peroxide, or other antimicrobial agents can treat superficial pyoderma and serve as adjunctive therapy in deeper infections. Regular bathing with antimicrobial shampoos helps reduce surface bacterial numbers, remove crusts and debris, and deliver medication directly to the affected skin.
Trade-offs: Topical therapy requires time commitment from owners and cooperation from the dog. Contact time is important — most medicated shampoos require 10 minutes of skin contact before rinsing to be effective. Topical therapy may be sufficient as sole treatment for mild superficial pyoderma but is usually combined with systemic antibiotics for more extensive or deep infections. The advantage of topical therapy includes reduced antibiotic resistance risk compared with systemic antibiotics alone.
Systemic antibiotic therapy
Oral antibiotics are the mainstay of treatment for moderate to severe or deep pyoderma. First-line empirical choices typically include cephalosporins, potentiated sulphonamides, or clindamycin. Current guidance favours shorter initial courses with re-assessment—around 2 weeks for superficial pyoderma and 3 weeks for deep pyoderma—with re-examination at that point to decide whether further treatment is needed, rather than a fixed long course.
Trade-offs: Prolonged antibiotic courses carry risks of gastrointestinal side effects, promote antibiotic resistance, and require owner compliance with regular dosing schedules. Premature discontinuation is a common cause of treatment failure and recurrence. Culture and sensitivity testing is increasingly important to ensure the chosen antibiotic is effective, particularly given the rising prevalence of methicillin-resistant organisms.
Addressing underlying triggers
Identifying and managing the predisposing cause is essential for preventing recurrence. This may involve implementing flea control, treating concurrent allergic skin disease with appropriate immunomodulatory or anti-pruritic medications, correcting endocrine imbalances, or addressing environmental factors such as moisture and skin fold management.
Trade-offs: Investigation of underlying causes can be time-consuming, expensive, and may require multiple diagnostic steps. However, failure to address the underlying trigger is the most common reason for pyoderma recurrence. The investment in diagnosis often proves cost-effective in the long term by reducing the frequency and severity of recurrent infections.
Management of resistant infections
Methicillin-resistant Staphylococcus pseudintermedius (MRSP) infections require antibiotic selection guided by culture and sensitivity results, with emphasis on topical therapy to reduce systemic antibiotic use. In some cases, combination approaches using aggressive topical therapy with targeted systemic antibiotics selected on sensitivity results may be necessary.
Trade-offs: Resistant infections are more challenging and costly to manage, require stricter compliance, and may have longer treatment durations. They also carry hygiene implications, as resistant organisms can potentially transfer between animals and, less commonly, to humans. Environmental decontamination, hand hygiene, and restriction of contact with immunocompromised individuals may be recommended during treatment.
Common misconceptions
"Pyoderma is caused by poor hygiene or dirty living conditions"
Pyoderma is caused by disruption of the normal skin barrier that allows resident bacteria to invade deeper skin layers. It is not a result of poor hygiene. In fact, over-bathing with harsh shampoos can strip natural skin oils and disrupt the skin barrier, potentially increasing susceptibility. The bacteria involved — primarily Staphylococcus pseudintermedius — are normal inhabitants of healthy canine skin that cause problems only when the skin's defences are compromised.
"Pyoderma is contagious to other dogs or to humans"
The most common cause of canine pyoderma, Staphylococcus pseudintermedius, is species-adapted and does not typically colonise or infect humans or other species. The infection develops from the dog's own resident skin flora rather than from external sources. However, methicillin-resistant strains can occasionally be shared between animals in close contact, and basic hygiene measures are sensible during treatment of resistant infections.
"A short course of antibiotics is sufficient to clear pyoderma"
One of the most common reasons for treatment failure and recurrence is insufficient duration of antibiotic therapy. Current guidance favours an initial course of around 2 weeks for superficial pyoderma and 3 weeks for deep pyoderma, with re-examination at that point to decide whether further treatment is needed. Stopping antibiotics prematurely when lesions appear to have resolved often leads to rapid recurrence as surviving bacteria proliferate.
Related conditions
Malassezia Dermatitis
Malassezia dermatitis often develops alongside pyoderma, particularly when the skin's normal defences have been compromised by allergy, moisture, or hormonal changes. Both conditions involve overgrowth of organisms that live harmlessly on healthy skin, and they can appear together in the same lesions or body regions.
Demodectic Mange
Demodectic mange can predispose to pyoderma because the mite proliferation and immune response disrupt the skin's barrier and create an environment in which bacteria multiply more easily. Many dogs with demodectic mange develop secondary bacterial infection, and treating both the mites and the bacteria tends to form part of the same clinical picture.
Flea Allergy Dermatitis
Flea allergy dermatitis is one of the more common underlying causes of pyoderma in dogs. The intense itching and inflammation triggered by flea saliva can damage the skin barrier, allowing bacteria to invade and establish infection in areas of scratching, licking, or moisture.
Food Allergy in Dogs
Food allergy in dogs can drive chronic or recurrent pyoderma, because the persistent itch and inflammation weaken the skin's defences and create opportunities for bacterial overgrowth. In these cases, addressing the allergy tends to be part of the strategy for controlling the infection.
Skin Fold Dermatitis
Skin fold dermatitis describes pyoderma that develops in the warm, moist environment of deep skin folds, where reduced airflow and friction create conditions that favour bacterial multiplication. The infection in these areas follows the same bacterial patterns seen elsewhere, but the anatomical site shapes the clinical presentation and management approach.
Understanding that pyoderma is almost always a secondary problem — developing because something else has compromised the skin's natural defences — reframes the approach from simply treating the infection to also understanding why it developed. Dogs that experience a single episode of pyoderma that resolves completely with treatment may not require extensive investigation. However, dogs that experience recurring episodes are very likely to have an underlying trigger that, once identified and managed, can substantially reduce the frequency and severity of future infections. Common underlying triggers include allergic skin disease, parasites, and hormonal imbalances, each of which has its own management pathway.
Last reviewed: 24 April 2026 · Dr Alastair Greenway MRCVS